Jinguan Lin

3.3k total citations · 3 hit papers
42 papers, 1.9k citations indexed

About

Jinguan Lin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinguan Lin has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinguan Lin's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Jinguan Lin is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Jinguan Lin collaborates with scholars based in China, United States and France. Jinguan Lin's co-authors include Qianjin Liao, Linda Oyang, Longzheng Xia, Shiming Tan, Yujuan Zhou, Yanyan Tang, Yaqian Han, Jiaxin Liang, Shan Rao and Xia Luo and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Scientific Reports.

In The Last Decade

Jinguan Lin

41 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cancer metabolic reprogramming and immune response

2021 799 citations Longzheng Xia, Linda Oyang et al. Molecular Cancer profile →
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

2023 121 citations Xuemeng Xu, Peng Qiu et al. Experimental & Molecular Medicine profile →
Endoplasmic reticulum stress—a key guardian in cancer

2024 62 citations Wenlong Zhang, Yidan Shi et al. Cell Death Discovery profile →

Peers

Jinguan Lin

ONCOL

IMMUN

PRM

Jundong Zhou China

Shanmugasundaram Ganapathy‐Kanniappan United States

Susan Mason United Kingdom

Shuang Li China

Yu‐Ting Chou Taiwan

Chaoyun Pan China

Min Su China

Abhinav Achreja United States

Shan Rao China

Jundong Zhou China

Jinguan Lin

1.2k ×1.0

713 ×0.8

386 ×1.0

ONCOL

193 ×0.5

IMMUN

215 ×0.8

PRM

Citations per year, relative to Jinguan Lin Jinguan Lin (= 1×) peers Jundong Zhou

Countries citing papers authored by Jinguan Lin

Since Specialization

Citations

This map shows the geographic impact of Jinguan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinguan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinguan Lin more than expected).

Fields of papers citing papers by Jinguan Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinguan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinguan Lin. The network helps show where Jinguan Lin may publish in the future.

Co-authorship network of co-authors of Jinguan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jinguan Lin. A scholar is included among the top collaborators of Jinguan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinguan Lin. Jinguan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Haoneng, Peng Qiu, Linda Oyang, et al.. (2025). Fusion genes in cancers: Biogenesis, functions, and therapeutic implications. Genes & Diseases. 12(5). 101536–101536.

Qiu, Peng, Lujuan Wang, Ying Long, et al.. (2025). SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression. Journal of Advanced Research. 79. 505–520. 3 indexed citations

Qiu, Peng, Xuemeng Xu, Wenlong Zhang, et al.. (2025). Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance. International Journal of Biological Sciences. 21(7). 2991–3010. 3 indexed citations

Tan, Shiming, Shizhen Li, Longzheng Xia, et al.. (2025). Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway. International Journal of Oncology. 66(3). 1 indexed citations

Han, Yaqian, Shizhen Li, Linda Oyang, et al.. (2025). Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential. Cellular Oncology. 48(5). 1219–1244. 1 indexed citations

Wang, Jiewen, Mingjing Peng, Linda Oyang, et al.. (2025). Mechanism and application of lactylation in cancers. Cell & Bioscience. 15(1). 76–76. 4 indexed citations

Jiang, Xianjie, Qiu Peng, Mingjing Peng, et al.. (2024). Cellular metabolism: A key player in cancer ferroptosis. Cancer Communications. 44(2). 185–204. 36 indexed citations

Jiang, Xianjie, Mingjing Peng, Qiang Liu, et al.. (2024). Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Molecular Cancer. 23(1). 151–151. 13 indexed citations

Ruan, Dan‐Yun, Fei Han, Fenghua Wang, et al.. (2024). Preliminary results of phase I/II study to evaluate safety and efficacy of combination pucotenlimab with epidermal growth factor receptor-ADC (EGFR-ADC) MRG003 in patients with EGFR positive solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 6013–6013. 5 indexed citations

10.

Zhang, Wenlong, Yidan Shi, Linda Oyang, et al.. (2024). Endoplasmic reticulum stress—a key guardian in cancer. Cell Death Discovery. 10(1). 343–343. 62 indexed citations breakdown →

11.

Xia, Longzheng, Jinguan Lin, Mingjing Peng, et al.. (2024). Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination. International Journal of Biological Sciences. 20(4). 1125–1141. 8 indexed citations

12.

Xu, Xuemeng, Qiu Peng, Xianjie Jiang, et al.. (2024). Altered glycosylation in cancer: molecular functions and therapeutic potential. Cancer Communications. 44(11). 1316–1336. 39 indexed citations

13.

Li, Shizhen, Mingjing Peng, Shiming Tan, et al.. (2024). The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. Cancer Cell International. 24(1). 37–37. 15 indexed citations

14.

Zeng, Hui, Jinfeng Wang, Hongyu Deng, et al.. (2023). Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma. Oncology Reports. 49(5). 6 indexed citations

15.

Xu, Xuemeng, Peng Qiu, Xianjie Jiang, et al.. (2023). Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Experimental & Molecular Medicine. 55(7). 1357–1370. 121 indexed citations breakdown →

16.

Li, Xin, et al.. (2022). Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer. Frontiers in Immunology. 13. 988416–988416. 14 indexed citations

17.

Rao, Shan, Linda Oyang, Jiaxin Liang, et al.. (2021). Biological Function of HYOU1 in Tumors and Other Diseases. OncoTargets and Therapy. Volume 14. 1727–1735. 33 indexed citations

18.

Tan, Shiming, Pin Yi, Heran Wang, et al.. (2020). RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer. Frontiers in Oncology. 10. 649–649. 21 indexed citations

19.

Feng, Yuhua, Jinguan Lin, Yiping Liu, et al.. (2019). Investigation of expressions of PDK1, PLK1 and c‐Myc in diffuse large B‐cell lymphoma. International Journal of Experimental Pathology. 100(1). 32–40. 16 indexed citations

20.

Zuo, Chaohui, et al.. (2014). Characterization of lymph node metastasis and its clinical significance in the surgical treatment of gastric cancer. Molecular and Clinical Oncology. 2(5). 821–826. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact